Investment Banking

Zaoui brothers’ Spac Odyssey takes drugmaker public in €1.5bn deal

Michael and Yoël Zaoui’s Odyssey Acquisition will combine with BenevolentAI in a deal that values the company at €1.5bn
Michael and Yoël Zaoui’s Odyssey Acquisition will combine with BenevolentAI in a deal that values the company at €1.5bn

Investment banking brothers, Michael and Yoël Zaoui, are set to take a UK startup that uses artificial intelligence to develop drugs public through their blank-cheque company unveiled in June.

Odyssey Acquisition, the Zaoui brothers' €300m special purpose acquisition company, will combine with BenevolentAI in a deal that values the company at €1.5bn, according to a statement from the firm.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump